Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study

Platzbecker, UweUwePlatzbeckerBraulke, FriederikeFriederikeBraulkeKuendgen, A.A.KuendgenGoetze, K.K.GoetzeBug, G.G.BugSchoenefeldt, ClaudiaClaudiaSchoenefeldtShirneshan, KatayoonKatayoonShirneshanRoellig, ChristophChristophRoelligBornhaeuser, MartinMartinBornhaeuserNaumann, R.R.NaumannNeesen, J.J.NeesenGiagounidis, Aristoteles A. N.Aristoteles A. N.GiagounidisHofmann, W-KW-KHofmannEhninger, G.G.EhningerGerming, U.U.GermingHaase, DetlefDetlefHaaseWermke, MartinMartinWermke2018-11-072018-11-072013https://resolver.sub.uni-goettingen.de/purl?gro-2/29759Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I studyjournal_article10.1038/leu.2013.2623354011000319917500025